Pierre Vabres

机构：Inserm, Université de Bourgogne, CHU Dijon Bourgogne · ORCID：0000-0001-8693-3183

发表论文 423 篇 · 总被引 16871 次 · h-index 55

代表论文

• Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS) (2023 · Genetics in Medicine · 被引 100)
• Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023 · Genome Medicine · 被引 78)
• Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy (2024 · JAMA Dermatology · 被引 32)
• Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases (2024 · The Journal of Experimental Medicine · 被引 20)
• Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis (2023 · Journal of the European Academy of Dermatology and Venereology · 被引 16)
• Low risk of embryonic and other cancers in PIK3CA ‐related overgrowth spectrum: Impact on screening recommendations (2023 · Clinical Genetics · 被引 14)